https://www.marketscreener.com/quote/stock/KIORA-PHARMACEUTICALS-INC-18138378/news/Kiora-Pharmaceuticals-Reports-Q3-2023-Results-Expanding-Clinical-Development-of-KIO-301-for-Inherit-45285670/?utm_source=telegram&utm_medium=social&utm_campaign=share